DPY19L1 and cancer: Increased expression levels of HLF, shown to promote cell-cycle progression in various cancers [58], ITGA2, MUC1, and DPY19L1 have also been proposed to confer prognostic value for the survival of patients suffering from LUAD malignancies [59,60,61,62,63,64].